{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:20:00Z","timestamp":1794900000868,"version":"4.9.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The incidence of alcoholic liver disease (ALD) in China has been increasing in recent years, causing serious socioeconomic and public health burden. However, the treatment of ALD lacks a clear, unified, and effective plan. However, there is still lack of systematic analysis and evaluation of the efficacy and safety of probiotic in the treatment of ALD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A computerized search was performed to identify randomized controlled trials of probiotic and combined probiotic therapy in alcohol-induced liver injury. The control group received placebo or conventional treatment. Retrieval period from database creation to January7, 2022. Both investigators independently searched literature, extracted data, and assessed risk of bias using RevMan 5.4 software and rated the quality of the level of evidence for the outcome indicators according to the GRADE criteria evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Altogether 10 studies with 835 patients were included. Meta-analysis showed significantly better liver function in test group than control group. The inflammatory level in the experimental group was significantly lower than that in the control group. The intestinal flora of the experimental group was effectively improved. But only\n                      <jats:italic toggle=\"yes\">Bifidobacteria<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Lactobacilli<\/jats:italic>\n                      were indigenous; meta-analysis showed that the adverse reactions in the experimental group were slightly higher than those in the control group, but the results were insignificant. Current evidence shows that compared with conventional therapy, probiotic or probiotic combination therapy can effectively improve liver function, modulate the gut microbiota environment, and reduce inflammation in alcoholic liver by modulating the gut microbiota, but the safety needs further investigation. There are limitations in the quantity and quality of the included trials.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study shows that the use of probiotics therapy has a good regulating effect on liver function, intestinal flora, inflammatory level, and blood lipid level in ALD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000043662","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T19:01:29Z","timestamp":1755198089000},"page":"e43662","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Safety and efficacy of probiotics in the treatment of ALD"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3684-1616","authenticated-orcid":false,"given":"Xiangyu","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Rehabilitation Medicine, Second Affiliated Hospital of Chengdu Medical College and 416 Hospital of Nuclear Industry, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3684-9400","authenticated-orcid":false,"given":"Shuxi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Second Affiliated Hospital of Chengdu Medical College and 416 Hospital of Nuclear Industry, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261117","first-page":"188","article-title":"Guidelines of prevention and treatment for alcoholic liver disease: a 2018 update.","volume":"26","year":"2018","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"R2-20261117","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12916-014-0159-5","article-title":"The global burden of liver disease: a challenge for methods and for public health.","volume":"12","author":"Byass","year":"2014","journal-title":"BMC Med"},{"key":"R3-20261117","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases.","volume":"146","author":"Schnabl","year":"2014","journal-title":"Gastroenterology"},{"key":"R4-20261117","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3748\/wjg.v16.i11.1321","article-title":"Alcoholic liver disease and the gut\u2013liver axis.","volume":"16","author":"Szabo","year":"2010","journal-title":"World J Gastroenterol"},{"key":"R5-20261117","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4291\/wjgp.v5.i4.514","article-title":"Alterations of the gut microbiome and metabolome in alcoholic liver disease.","volume":"5","author":"Zhong","year":"2014","journal-title":"World J Gastrointest Pathophysiol"},{"key":"R6-20261117","first-page":"121","article-title":"Protective effect of Lactobacillus casei on acrylamide-induced intestinal injury in rats.","volume":"39","author":"Tianjiao","year":"2018","journal-title":"Food Sci"},{"key":"R7-20261117","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jhep.2016.11.008","article-title":"Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.","volume":"66","author":"Ferrere","year":"2017","journal-title":"J Hepatol"},{"key":"R8-20261117","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1017\/S095442241700018X","article-title":"Probiotics, prebiotics, synbiotics, and insulin sensitivity.","volume":"31","author":"Kim","year":"2018","journal-title":"Nutr Res Rev"},{"key":"R10-20261117","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.alcohol.2008.08.006","article-title":"Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study.","volume":"42","author":"Kirpich","year":"2008","journal-title":"Alcohol"},{"key":"R11-20261117","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s12072-012-9408-x","article-title":"Probiotics promote rapid-turnover protein production by restoring gut flora in patients with alcoholic liver cirrhosis.","volume":"7","author":"Koga","year":"2013","journal-title":"Hepatol Int"},{"key":"R12-20261117","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/MEG.0000000000000458","article-title":"Effects of probiotics (cultured Lactobacillus subtilis\/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study.","volume":"27","author":"Han","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R13-20261117","first-page":"178","article-title":"Clinical observation on the treatment of alcoholic liver disease with montelukast and Bifidobacterium trituberculatum combined with Ginseng lingbaijusan.","volume":"28","author":"Zhu","year":"2018","journal-title":"J Integr Med Liver Dis"},{"key":"R14-20261117","first-page":"82","article-title":"Effect of live Clostridium typhimurium tablets combined with polyene-phosphatidylcholine on intestinal flora and inflammatory factors in patients with alcoholic liver disease.","volume":"31","author":"Zhu","year":"2019","journal-title":"Chin J Microecol"},{"key":"R15-20261117","first-page":"593","article-title":"Efficacy of Bifidobacterium tetrasporium tablets in the adjuvant treatment of alcoholic liver and changes in intestinal flora.","volume":"24","author":"Zhang","year":"2020","journal-title":"Anhui Med"},{"key":"R16-20261117","first-page":"40","article-title":"Effects of Bifidobacterium tetradecanoides tablets combined with montelukast on intestinal flora and liver function in patients with alcoholic liver disease.","volume":"30","author":"Zhou","year":"2020","journal-title":"J Shanxi Health Health Prof Coll"},{"key":"R17-20261117","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/s41430-020-00852-8","article-title":"Effect of Lactobacillus casei on lipid metabolism and intestinal microflora in patients with alcoholic liver injury.","volume":"75","author":"Li","year":"2021","journal-title":"Eur J Clin Nutr"},{"key":"R18-20261117","first-page":"796","article-title":"Effect of reduced glutathione combined with Bifidobacterium tetrasporium tablets on intestinal flora in patients with alcoholic liver disease.","volume":"29","author":"Zhang","year":"2021","journal-title":"Chin J Integr Med Digestion"},{"key":"R19-20261117","first-page":"75","article-title":"Efficacy of live Clostridium typhimurium adjuvant to thioprostenol and metadoxine in the treatment of patients with alcoholic liver disease and its effect on the distribution of intestinal flora in patients.","volume":"24","author":"Wu","year":"2021","journal-title":"J Pract Liver Dis"},{"key":"R20-20261117","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL clinical practice guidelines: management of alcohol-related liver disease.","volume":"69","author":"Ofliver","year":"2018","journal-title":"J Hepatol"},{"key":"R21-20261117","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/flgastro-2013-100373","article-title":"Diagnosis and treatment of alcoholic hepatitis.","volume":"5","author":"Parker","year":"2014","journal-title":"Frontline Gastroenterol"},{"key":"R22-20261117","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","article-title":"Gut microbiome, liver immunology, and liver diseases.","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"R23-20261117","doi-asserted-by":"crossref","first-page":"e107265","DOI":"10.1371\/journal.pone.0107265","article-title":"IL-1 signaling in obesity-induced hepatic lipogenesis and steatosis.","volume":"9","author":"Negrin","year":"2014","journal-title":"PLoS One"},{"key":"R24-20261117","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hep.31178","article-title":"Fecal microbiome distinguishes alcohol consumption from alcoholic hepatitis but does not discriminate disease severity.","volume":"72","author":"Smirnova","year":"2020","journal-title":"Hepatology"},{"key":"R25-20261117","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease.","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:02:28Z","timestamp":1794898948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":24,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043662","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"2024-11-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}